PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2014

PHARMANIAGA BERHAD

Financial Year End

31/12/2014
Quarter4
Quarterly report for the financial period ended31/12/2014
The figureshave not been audited

Attachments

Pharma Q4 1214.pdf
237 KB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2014

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2014
31/12/2013
31/12/2014
31/12/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
627,103
567,860
2,122,933
1,946,639
2Profit/(loss) before tax
37,854
33,007
125,580
92,997
3Profit/(loss) for the period
36,621
21,267
94,225
56,761
4Profit/(loss) attributable to ordinary equity holders of the parent
36,697
20,813
93,844
55,200
5Basic earnings/(loss) per share (Subunit)
14.18
8.04
36.25
21.32
6Proposed/Declared dividend per share (Subunit)
12.00
6.20
28.00
16.02


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.0300
1.8800
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced23 Feb 2015  
CategoryFinancial Results
Reference NoPB-150216-76B77